These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29927585)

  • 1. Bioorthogonal Removal of 3-Isocyanopropyl Groups Enables the Controlled Release of Fluorophores and Drugs in Vivo.
    Tu J; Xu M; Parvez S; Peterson RT; Franzini RM
    J Am Chem Soc; 2018 Jul; 140(27):8410-8414. PubMed ID: 29927585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isonitrile-responsive and bioorthogonally removable tetrazine protecting groups.
    Tu J; Svatunek D; Parvez S; Eckvahl HJ; Xu M; Peterson RT; Houk KN; Franzini RM
    Chem Sci; 2020 Jan; 11(1):169-179. PubMed ID: 32110368
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide
    Wu J; Sun T; Yang C; Lv T; Bi Y; Xu Y; Ling Y; Zhao J; Cong R; Zhang Y; Wang J; Wen H; Jiang H; Li F; Huang Z
    Biomater Sci; 2021 Mar; 9(5):1816-1825. PubMed ID: 33458722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold-Triggered Uncaging Chemistry in Living Systems.
    Pérez-López AM; Rubio-Ruiz B; Sebastián V; Hamilton L; Adam C; Bray TL; Irusta S; Brennan PM; Lloyd-Jones GC; Sieger D; Santamaría J; Unciti-Broceta A
    Angew Chem Int Ed Engl; 2017 Oct; 56(41):12548-12552. PubMed ID: 28699691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociative reactions of benzonorbornadienes with tetrazines: scope of leaving groups and mechanistic insights.
    Xu M; Galindo-Murillo R; Cheatham TE; Franzini RM
    Org Biomol Chem; 2017 Nov; 15(46):9855-9865. PubMed ID: 29139516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External-Radiation-Induced Local Hydroxylation Enables Remote Release of Functional Molecules in Tumors.
    Fu Q; Li H; Duan D; Wang C; Shen S; Ma H; Liu Z
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21546-21552. PubMed ID: 32729159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning Isonitrile/Tetrazine Chemistry for Accelerated Deprotection and Formation of Stable Conjugates.
    Xu M; Deb T; Tu J; Franzini RM
    J Org Chem; 2019 Dec; 84(23):15520-15529. PubMed ID: 31724861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociative Bioorthogonal Reactions.
    Tu J; Xu M; Franzini RM
    Chembiochem; 2019 Jul; 20(13):1615-1627. PubMed ID: 30695126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and efficient tetrazine-induced drug release from highly stable benzonorbornadiene derivatives.
    Xu M; Tu J; Franzini RM
    Chem Commun (Camb); 2017 Jun; 53(46):6271-6274. PubMed ID: 28548143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caged cyclopropenes for controlling bioorthogonal reactivity.
    Kumar P; Jiang T; Li S; Zainul O; Laughlin ST
    Org Biomol Chem; 2018 Jun; 16(22):4081-4085. PubMed ID: 29790564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Assembly of a Tripodal Triszwitterion Forms a pH-Switchable Hydrogel that Can Reversibly Encapsulate Hydrophobic Guests in Water.
    Jana P; Schmuck C
    Chemistry; 2017 Jan; 23(2):320-326. PubMed ID: 27436083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled SLN Delivery by Thermoresponsive In-situ Forming Erodible Gels; A Whole-body and Organ Imaging Study.
    Dorraj G; Dadashzadeh S; Erfan M; Moghimi HR
    Curr Drug Deliv; 2018; 15(4):510-519. PubMed ID: 29422000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of mexitil-depot in patients with chronic ventricular arrhythmia].
    Golikov AP; Botolova EN; Rudnev DV
    Klin Med (Mosk); 1995; 73(6):45-6. PubMed ID: 8691782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers.
    Otani M; Fukuda T; Naohara M; Maune H; Senda C; Yamamoto I; Azuma J
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):395-9. PubMed ID: 12937870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mexiletine, an anti-arrhythmia agent for acute stage of myocardial infarction].
    Hayakawa H; Ino T
    Nihon Rinsho; 1983 Dec; 41(12):2748-55. PubMed ID: 6674559
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual-drug encapsulation and release from core-shell nanofibers.
    Su Y; Su Q; Liu W; Jin G; Mo X; Ramakrishn S
    J Biomater Sci Polym Ed; 2012; 23(7):861-71. PubMed ID: 21418751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
    Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
    J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mexiletine for lidocaine-responsive neonatal epilepsy.
    Nakazawa M; Okumura A; Niijima S; Yamashita S; Shimono K; Hirose S; Shimizu T
    Brain Dev; 2013 Aug; 35(7):667-9. PubMed ID: 23182886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.